Skip to content

Reconstruction in osteomyelitis

Primary (Immediate) Reconstruction Using Nonvascularized Bone Grafts For Large Defects in Mandibular Chronic Suppurative Osteomyelitis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230616002
Enrollment
21
Registered
2023-06-16
Start date
2017-01-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteomyelitis of the mandible Osteomyelitis Mandible Reconstruction Immediate Delayed graft

Interventions

En-bloc marginal resection will be performed to the normally bleeding bone followed by freeing the cut segment from the soft tissue coverage
to be removed. If IAN is encountered, it will be delicately freed from the cut segment. Immediate resection will be performed using bone block(s) from the anterior iliac crest and will be fixed in pla
Experimental Procedure/Surgery
primary reconstruction of osteomyelitis defects

Sponsors

Mosaad Khalifah
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Patients diagnosed with chronic suppurative osteomyelitis of the mandible based on the clinical picture (pain, tenderness, fever, lymphadenitis, painful or painless swelling, intraoral and or skin fistula(e), purulent discharge, hypoesthesia of the inferior dental nerve (IAN), and trismus), radiographic examination (moth-eaten appearance), and the histopathologic examination (necrotic bone, granulation tissue, inflammatory cells, and blood vessel thrombosis). 2 The proposed resection size be 6 cm or more; however, with the presence of sufficient mandibular bone at the inferior border of the mandible following the proposed marginal resection.

Exclusion criteria

Exclusion criteria: 1 The more extensive involvement of the mandible necessitating segmental resection 2 History of recent head or neck radiotherapy, concurrent head or neck radiotherapy, co-presence of malignancies, kidney-, liver-, or heart failure, any other bone marrow diseases, and immune diseases.

Design outcomes

Primary

MeasureTime frame
osteomyelitis eradication at 12 months eradicated/Not

Secondary

MeasureTime frame
graft success/failure at 12 months succeeded/Not

Countries

Egypt

Contacts

Public ContactMosaad Kahlifah

Kafrelsheikh University

mosaadkhalifah@ymail.com0021008603084

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026